Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synovial Telocytes are Characterized by Efhd1, Dpp4, and Pi16 Expression, Show High Responsiveness to Osmotic Stress, and Exhibit Fibroblast Plasticity Potential.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Osteomyelitis.

Nature reviews. Disease primers·2026
Same author

Anti-IsdB Antibody-Secreting Cells Found in S. aureus-Infected Periprosthetic Bone Marrow: Case Series of Total Hip Arthroplasty Patients.

Medical research archives·2026
Same author

Influence of Area Deprivation Index and Social Vulnerability Index on PROMIS Outcomes and MCID Achievement Following ACL Reconstruction.

Orthopaedic journal of sports medicine·2026
Same author

Concentration and Frequency of Intraoperative Irrigation as a Strategy Against Implant-Associated Infection: Insights from a Preclinical Rat Model: Commentary on an article by Musashi Ima, MD, et al.: "Diluted Povidone-Iodine Irrigation for Prevention of Implant-Related Infection. A Comparative Analysis of Concentration and Frequency in a Rat Model".

The Journal of bone and joint surgery. American volume·2026
Same author

Dual-Scale StaphAIR: Predictive Modeling for the Diagnosis of <i>S. aureus</i> Infection via Simultaneous Detection and Quantification of Cytokines and Antibodies.

Analytical chemistry·2026

Related Experiment Video

Updated: May 19, 2026

Preparation, Procedures and Evaluation of Platelet-Rich Plasma Injection in the Treatment of Knee Osteoarthritis
14:38

Preparation, Procedures and Evaluation of Platelet-Rich Plasma Injection in the Treatment of Knee Osteoarthritis

Published on: January 4, 2019

Platelet-rich plasma therapy - future or trend?

Robinder S Dhillon, Edward M Schwarz, Michael D Maloney

    Arthritis Research & Therapy
    |August 17, 2012
    PubMed
    Summary
    This summary is machine-generated.

    Platelet-rich plasma (PRP) offers potential for healing musculoskeletal injuries by concentrating growth factors. Further research is needed to understand its mechanism and overcome current limitations for wider acceptance.

    More Related Videos

    Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion
    08:34

    Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion

    Published on: February 24, 2021

    Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
    05:57

    Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

    Published on: August 2, 2022

    Related Experiment Videos

    Last Updated: May 19, 2026

    Preparation, Procedures and Evaluation of Platelet-Rich Plasma Injection in the Treatment of Knee Osteoarthritis
    14:38

    Preparation, Procedures and Evaluation of Platelet-Rich Plasma Injection in the Treatment of Knee Osteoarthritis

    Published on: January 4, 2019

    Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion
    08:34

    Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion

    Published on: February 24, 2021

    Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
    05:57

    Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

    Published on: August 2, 2022

    Area of Science:

    • Orthobiologics
    • Regenerative Medicine
    • Musculoskeletal Repair

    Background:

    • Chronic musculoskeletal injuries present significant healing challenges.
    • Orthobiologics, including cell-based therapies, show promise for accelerating tissue repair.
    • Platelet-rich plasma (PRP) is an emerging orthobiologic gaining traction for musculoskeletal injuries.

    Purpose of the Study:

    • To review the biological activity factors of PRP.
    • To examine pre-clinical and clinical evidence supporting PRP's efficacy.
    • To discuss current PRP preparation techniques and limitations.

    Main Methods:

    • Literature review of pre-clinical and clinical studies on PRP.
    • Analysis of proposed biological mechanisms of PRP.
    • Description of current PRP preparation methods and technologies.

    Main Results:

    • PRP contains concentrated growth factors (e.g., PDGF, TGF-β, VEGF) crucial for tissue repair.
    • PRP enhances bone and soft-tissue healing by delivering supra-physiological platelet concentrations.
    • Evidence supports PRP's potential, but a significant knowledge gap exists regarding its precise mechanism of action.

    Conclusions:

    • PRP is a promising therapeutic for regenerative treatments due to ease of preparation, safety, and potential benefits.
    • Understanding PRP's mechanism of action is critical to address skepticism and improve clinical outcomes.
    • Overcoming current limitations in PRP therapy is essential for its broad acceptance in clinical practice.